Early Steps in the Value of Cancer Care—Many Paths Remain Unexplored

Daniel A. Goldstein; Carlo La Vecchia; Bernardo H. L. Goulart

doi:10.1634/theoncologist.2017-0611

Related publications

Article2026

The direct costs of cancer care: a review of recent trends and variations in 39 countries

Preston Ngo, Richa Shah, J Vignat, Louisa Collins, Lucy Cunnama, Inuk Hwang, Freddie Ian Bray, K. Robin Yabroff, I Soerjomataram

Article2021

How the COVID-19 pandemic will change the future of critical care

Yaseen M. Arabi, Élie Azoulay, Hasan M. Al‐Dorzi, Jason Phua, Jorge I. Salluh, Alexandra Binnie, Carol Hodgson, Derek C. Angus, Maurizio Cecconi, Bin Du, Rob Fowler, Charles D. Gomersall, Peter Horby, Nicole P. Juffermans, Jozef Kesecioğlu, Ruth Kleinpell, F.S. Machado, Greg S. Martin, Geert Meyfroidt, Andrew Rhodes, Kathy Rowan, Jean‐François Timsit, Jean Louis Vincent, Giuseppe Citerio

Article2013

Evaluating the validity of quality indicators for colorectal cancer care

G.A. Gooiker, N.E. Kolfschoten, Esther Bastiaannet, Cornelis J.�H. van de Velde, E.H. Eddes, Erwin van der Harst, Theo Wiggers, Frits R. Rosendaal, Rob A.�E.�M. Tollenaar, Michel W.J.M. Wouters

Journal of Surgical Oncology

Article2023

Do investments in cancer registry databases and tools bring added value? NORDCAN as an example

Hans H. Storm, Siri Larønningen, Freddie Ian Bray

Letter2022

Listening to the Patient Voice Adds Value to Cancer Clinical Trials

Michael Brundage, Norah L. Crossnohere, Jennifer O’Donnell, Samantha Cruz Rivera, Roger Wilson, Albert W. Wu, David Moher, Derek Kyte, Bryce B. Reeve, Alexandra Gilbert, Ronald C. Chen, Melanie Calvert, Claire Snyder